Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $3.67 Million - $4.65 Million
-20,000 Reduced 33.33%
40,000 $7.5 Million
Q1 2023

May 15, 2023

BUY
$193.75 - $232.55 $11.6 Million - $14 Million
60,000 New
60,000 $14 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $8.19 Million - $10.5 Million
46,200 Added 46.2%
146,200 $27.9 Million
Q4 2021

Feb 14, 2022

SELL
$347.28 - $421.83 $3.82 Million - $4.64 Million
-11,000 Reduced 9.91%
100,000 $38 Million
Q3 2021

Nov 16, 2021

BUY
$405.61 - $524.84 $12.5 Million - $16.1 Million
30,700 Added 38.23%
111,000 $45 Million
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $28.1 Million - $36.3 Million
75,300 Added 1506.0%
80,300 $38 Million
Q1 2021

May 17, 2021

SELL
$361.28 - $504.76 $1.08 Million - $1.51 Million
-3,000 Reduced 37.5%
5,000 $1.92 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $2.34 Million - $2.97 Million
8,000 New
8,000 $2.96 Million
Q3 2020

Nov 16, 2020

SELL
$268.51 - $400.74 $10.7 Million - $16 Million
-40,000 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$256.46 - $373.01 $20.5 Million - $29.8 Million
-80,000 Reduced 66.67%
40,000 $14.8 Million
Q1 2020

May 15, 2020

BUY
$209.2 - $335.53 $12.6 Million - $20.1 Million
60,000 Added 100.0%
120,000 $32.8 Million
Q4 2019

Feb 14, 2020

SELL
$288.29 - $335.49 $5.77 Million - $6.71 Million
-20,000 Reduced 25.0%
60,000 $19.9 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $5.34 Million - $7.56 Million
20,000 Added 33.33%
80,000 $24.3 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $18 Million - $22.1 Million
60,000 New
60,000 $22.1 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Qvt Financial LP Portfolio

Follow Qvt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Qvt Financial LP with notifications on news.